Boston Scientific

Open: 57.0 Close: 57.81 Change: 0.81

You don't have time to read all about Boston Scientific Stock. An AI summarizes all the information for you.

This document will help you to evaluate Boston Scientific without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Boston Scientific are: Boston, Scientific, employee, device, medical, announce, clinical, …

Concept Map

Semantic Network

Stock Summary

Boston Scientific develops, manufactures, and markets medical devices for use in various interventional medical specialties. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat.

Today's Summary

Boston Scientific to acquire Relievant Medsystems for $850 million upfront, plus milestone payments. Boston Scientific expects FDA approval for Farapoint in 2025. Average salary at Boston Scientific $60,291 yearly.

Today's News

Medical device company Boston Scientific announced the initiation of a clinical trial for one of its devices as a first-line treatment for persistent atrial fibrillation. Boston Scientific to acquire Relievant Medsystems for $850 million upfront, plus milestone payments. Boston Scientific ( NYSE:BSX – Get Free Report ) last released its earnings results on Thursday, October 26th. Boston Scientific had a net margin of 8.93% and a return on equity of 15.46%. TheStreet raised shares of Boston Scientific from a “c+” rating. Boston Scientific (NYSE:BSX) + announced today that it initiated the AVANT GUARD clinical trial to evaluate its Farapulse pulsed-field ablation (PFA) system. Boston Scientific expects FDA approval for Farapoint in 2025. Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. Boston Scientific had annual revenue of $12.68B with 6.68% growth in 2022. Territory Manager, Endoscopy - Albuquerque Work mode:  Field Based Territory:  United States Additional Location(s):  US-NM-Albuquerque; US- NM-Santa Fe. Structural Heart Valves Principal Clinical Specialist - Seattle, WA. The Interventional Cardiology team with Boston Scientific is looking for high energy, driven, passionate people, looking to not just change jobs, but start an amazing career! At Boston Scientific, our products and technologies are used to diagnose or treat a wide range of medical. Average salary at Boston Scientific $60,291 yearly. 54.0% of employees identify as members of the Democratic Party. Boston Scientific is ranked #58 on the Best Companies to Work For in Massachusetts list. Boston Scientific has 36,000 employees. 39% of Boston Scientific employees are women, while 61% are men. The average employee at Boston Scientific makes $60,291 per year. Boston Scientific generates $12.7B in revenue. Boston Scientific is in the medical device industry. The employee data is based on information from people who have self-report their past or current employments at Boston Scientific.

Stock Profile

"Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts."

Keywords

The game is changing. There is a new strategy to evaluate Boston Scientific fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Boston Scientific are: Boston, Scientific, employee, device, medical, announce, clinical, and the most common words in the summary are: boston, scientific, job, top, stock, remote, pay, . One of the sentences in the summary was: Boston Scientific expects FDA approval for Farapoint in 2025. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #boston #scientific #job #top #stock #remote #pay.